About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT05166733

A Retrospective Study of Reco Thrombectomy Stent for Intravascular Treatment of Acute Ischemic Stroke

To explore the differences in the green channel process of stroke in various regions of the same province, to target and shorten the time delay of emergency process, and to explore the key technologie...

Lead sponsor: PengYa•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jie Cao

CONTACT

13646125766 mayday509@163.com

Sponsors

Lead Sponsor

PengYa

Collaborators

Jingjiang People's Hospital
The Affiliated Hospital of Xuzhou Medical University
The Second Hospital of Nanjing Medical University
Northern Jiangsu People's Hospital
Yixing People's Hospital

The Reco Embolectomy Stent is indicated for patients who cannot be treated with intravenous tissue activator (IVt-PA) or who have failed IVt-PA therapy and is intended to remove thrombus from a large intracranial vessel in patients with ischemic stroke to restore blood flow.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient age ≥18 years
•The clinical diagnosis was acute ischemic stroke
•Large vascular lesions were detected by head CT, CTA, MRI, MRA or DSA
•Preoperative baseline NIHSS score \> 4
•MRS 0-1 before this stroke
•Mechanical thrombectomy was performed
•Use Reco thrombectomy bracket

Exclusion Criteria

•epileptic seizure
•Sudden coma
•Neurological loss symptoms quickly improved
•Imaging was negative, but clinical symptoms did not rule out subarachnoid hemorrhage
•Previous intracranial hemorrhage, subarachnoid hemorrhage, and brain tumor (with mass effect)
•History of head trauma within 3 months prior to surgery
•History of arterial puncture with difficulty in compression and hemostasis within one week prior to surgery
•Physical examination revealed evidence of active bleeding or trauma (e.g. fracture)
•Women are known to be pregnant or breastfeeding
•Severe allergies to contrast agents are known

Related studies

BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe

NCT06856902 · Cardiovascular Diseases, Endocrinology, and more

An Observational Study of the NeuroBell EEG Monitor

NCT07508670 · EEG, Neonatology, and more

Not Yet Recruiting

Assessment of Malnutrition in Hospitalized Patients: a Quasi Study

NCT07473492 · COPD , Neurology , ICU, Alzheimer, and more

Physician Diagnosis of Neurologic Cases With Large Language Models

NCT07344792 · Neurology

Not Yet RecruitingNA

Evaluation of A-DIVA Score Effectiveness at Admission for Preserving Venous Capital in Patients With Difficult Access

NCT06952829 · Internal Medicine, Surgery, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 22, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment300

Start dateDec 2021

Last updatedDec 22, 2021

Condition

Neurology Interventional Therapy

Locations shown

The First People's Hospital of Changzhou

Changzhou, Jiangsu

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 22, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions